149 related articles for article (PubMed ID: 31518985)
41. Taxanes for adjuvant treatment of early breast cancer.
Willson ML; Burke L; Ferguson T; Ghersi D; Nowak AK; Wilcken N
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD004421. PubMed ID: 31476253
[TBL] [Abstract][Full Text] [Related]
42. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
43. Coil embolization for intracranial aneurysms: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(1):1-114. PubMed ID: 23074479
[TBL] [Abstract][Full Text] [Related]
44. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
45. Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials.
Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Oct; 8(46):81204-81214. PubMed ID: 29113380
[TBL] [Abstract][Full Text] [Related]
46. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
Hoon SN; Lau PK; White AM; Bulsara MK; Banks PD; Redfern AD
Cochrane Database Syst Rev; 2021 May; 5(5):CD011220. PubMed ID: 34037241
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal treatment outcomes of recurrent clival chordomas: a single-center retrospective study.
Hong S; Mahajan A; Shinya Y; Laack NN; Link MJ; O'Brien EK; Stokken JK; Janus JR; Ho TP; Choby G; Van Gompel JJ
J Neurosurg; 2024 Apr; 140(4):920-928. PubMed ID: 37856417
[TBL] [Abstract][Full Text] [Related]
48. Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.
Xia H; Zhang W; Zhang Y; Shang X; Liu Y; Wang X
Front Oncol; 2022; 12():978069. PubMed ID: 36330494
[TBL] [Abstract][Full Text] [Related]
49. Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis.
Takumoto Y; Sasahara Y; Narimatsu H; Akazawa M
JAMA Netw Open; 2022 Jan; 5(1):e2145515. PubMed ID: 35099549
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of Systemic Treatments of Small Intestinal Adenocarcinomas: A Systematic Review and Meta-analysis.
de Back T; Nijskens I; Schafrat P; Chalabi M; Kazemier G; Vermeulen L; Sommeijer D
JAMA Netw Open; 2023 Feb; 6(2):e230631. PubMed ID: 36826817
[TBL] [Abstract][Full Text] [Related]
51. Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis.
Hu H; Xu ZY; Zhu Q; Liu X; Jiang SC; Zheng JH
Front Immunol; 2021; 12():669398. PubMed ID: 34335570
[TBL] [Abstract][Full Text] [Related]
52. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
Zhang Y; Ma JP; Weng JC; Wang L; Wu Z; Li D; Zhang JT
Neurosurg Rev; 2021 Apr; 44(2):1003-1015. PubMed ID: 32189095
[TBL] [Abstract][Full Text] [Related]
53. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.
Ma XJ; Li D; Wang L; Hao SY; Zhang LW; Zhang JT; Wu Z
Neurosurg Rev; 2020 Feb; 43(1):281-292. PubMed ID: 30535934
[TBL] [Abstract][Full Text] [Related]
54. Proposed Treatment Paradigm for Intracranial Chondrosarcomas Based on Multidisciplinary Coordination.
Li D; Weng JC; Zhang GJ; Hao SY; Tang J; Zhang LW; Wang L; Wu Z; Jia W; Zhang JT
World Neurosurg; 2018 Jan; 109():e517-e530. PubMed ID: 29033377
[TBL] [Abstract][Full Text] [Related]
55. Survival after radiofrequency ablation and/or chemotherapy for lung cancer and pulmonary metastases: a systematic review and meta-analysis.
Yang Z; Lyu X; Yang H; Wang B; Xu D; Huo L; Zhang R; Huang Y; Diao B
Front Immunol; 2023; 14():1240149. PubMed ID: 37869011
[TBL] [Abstract][Full Text] [Related]
56. Patterns of recurrence and disease progression in patients with positive-margin olfactory neuroblastoma following primary resection.
Bauman MMJ; Graves JP; Haller TJ; McMillan RA; Routman DM; Raghunathan A; Stokken JK; Link MJ; Moore EJ; Choby G; Van Gompel JJ
J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38518294
[TBL] [Abstract][Full Text] [Related]
57. Prognostic prediction by
Hu R; Zhang Y; Liu S; Lee P; Liu C; Liu A
Front Oncol; 2023; 13():1208531. PubMed ID: 37519817
[TBL] [Abstract][Full Text] [Related]
58. Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO).
Marino L; Lancellotta V; Franco P; Meattini I; Meduri B; Bernini M; Fabi A; Corvò R; Magrini SM; Pappagallo GL; Arcangeli S; D'Angelillo RM
Breast; 2021 Feb; 55():119-127. PubMed ID: 33445150
[TBL] [Abstract][Full Text] [Related]
59. Impact of Previous Local Treatment for Brain Metastases on Response to Molecular Targeted Therapy in BRAF-Mutant Melanoma Brain Metastasis: A Systematic Review and Meta-Analysis.
Liao G; Fu Y; Arooj S; Khan M; Li X; Yan M; Li Z; Yang H; Zheng T; Xu R
Front Oncol; 2022; 12():704890. PubMed ID: 35814449
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
